Free Trial

Bath & Body Works, Inc. (NYSE:BBWI) Position Decreased by GMT Capital Corp

Bath & Body Works logo with Retail/Wholesale background

GMT Capital Corp lowered its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 10.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,482,100 shares of the company's stock after selling 390,900 shares during the quarter. Bath & Body Works makes up about 6.6% of GMT Capital Corp's holdings, making the stock its 3rd biggest holding. GMT Capital Corp owned about 1.61% of Bath & Body Works worth $135,001,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in Bath & Body Works in the fourth quarter valued at $73,572,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of Bath & Body Works by 79.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,882,047 shares of the company's stock valued at $150,507,000 after acquiring an additional 1,715,096 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Bath & Body Works by 35.6% during the 4th quarter. Alliancebernstein L.P. now owns 5,178,447 shares of the company's stock worth $200,768,000 after acquiring an additional 1,360,264 shares in the last quarter. Anomaly Capital Management LP raised its position in shares of Bath & Body Works by 38.3% during the 4th quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company's stock worth $188,456,000 after acquiring an additional 1,346,752 shares in the last quarter. Finally, Champlain Investment Partners LLC purchased a new stake in Bath & Body Works during the fourth quarter worth approximately $37,853,000. Institutional investors and hedge funds own 95.14% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on BBWI. Citigroup cut their price objective on shares of Bath & Body Works from $48.00 to $36.00 and set a "buy" rating on the stock in a report on Monday, April 7th. The Goldman Sachs Group cut their price target on shares of Bath & Body Works from $49.00 to $42.00 and set a "buy" rating on the stock in a research note on Tuesday. Raymond James reduced their price target on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research report on Thursday, April 17th. Telsey Advisory Group reaffirmed an "outperform" rating and set a $43.00 price objective on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Piper Sandler raised Bath & Body Works from a "neutral" rating to an "overweight" rating and reduced their target price for the company from $38.00 to $35.00 in a report on Wednesday, April 9th. Four analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average target price of $42.69.

Check Out Our Latest Stock Report on Bath & Body Works

Bath & Body Works Stock Performance

Shares of BBWI opened at $28.77 on Wednesday. The stock has a market capitalization of $6.16 billion, a P/E ratio of 7.02, a P/E/G ratio of 0.92 and a beta of 1.69. The company's fifty day moving average is $31.83 and its two-hundred day moving average is $33.85. Bath & Body Works, Inc. has a 1 year low of $24.96 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. Sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.78%. The ex-dividend date was Friday, February 21st. Bath & Body Works's payout ratio is 21.98%.

Bath & Body Works announced that its Board of Directors has approved a stock repurchase plan on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its stock is undervalued.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Further Reading

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines